HVTN 142: A Phase 1 research study to test an experimental vaccine against HIV
Recruiting
18-55 years
All
1 Location
Brief description of study
The purpose of this study is to measure the safety, reactogenicity, and immunogenicity of VIR 1388 in adults in good health without HIV.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
healthy volunteers, healthy adults, healthy patient studies
-
Age: Between 18 Years - 55 Years
-
Gender: All
Please complete the pre-screener at the bottom of this page.
Updated on
09 Mar 2024.
Study ID: 853495
Pre-Screener
